Advertisement
Home Tags Therapy & Procedures: Misc.

Tag: Therapy & Procedures: Misc.

Early High-Titer Plasma Reduces Progression of COVID-19

0

Early administration of high-titer convalescent plasma against SARS-CoV-2 reduces progression in mildly ill older adults

HealthDay Reports: He Recovered From COVID-19. Can His Blood Help Others?

Red Cross Issues Call for More Blood Plasma to Treat COVID-19 Patients

0

People who have recovered from COVID-19 may have antibodies in their plasma that could boost immunity in current patients

Global Need High for Rehabilitation Services

0

Musculoskeletal disorders contributed most to prevalence; highest need for rehabilitation services seen in Western Pacific region

Los pacientes con la peor COVID-19 quizá sean los mejores donantes de plasma

COVID-19 Outcomes Not Improved With Convalescent Plasma

0

Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia

AHA: Care for Type 2 Myocardial Infarction Patients Varies

0

Just over half of patients with type 2 MI seen by a cardiologist in hospital; most did not see a cardiologist for follow-up care

Early ECMO-Facilitated Resuscitation Ups Survival in OHCA

0

Findings seen among adults with out-of-hospital cardiac arrest and refractory ventricular fibrillation

TAVR Volumes in the U.S. Have Risen Each Year Since 2011

0

In 2019, TAVR exceeded surgical procedures; 30-day mortality and stroke rates decreased since 2011

HealthDay Reports: Coronavirus Has Killed Thousands at US Nursing Homes

Nebulized Interferon Beta-1a Promising for COVID-19

0

Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement

HealthDay Reports: Preoperative COVID-19 Incidence

Risks of Opioids Should Be Recognized for Children After Surgery

0

Opioid prescribing guidelines for children developed; authors underscore importance of nonopioid analgesic options, providing education to patients and their families

Paran un ensayo de un medicamento de anticuerpos contra la COVID-19 por falta de efectividad

New Cancer Drug Approvals Linked to Drop in Mortality

0

New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.